ESCMID Logo

23 June 2015

Dear Colleagues,



Having trouble viewing this email? View in your browser.

CMI impact factor increases again in 2014

The 2014 impact factors have just been released! The impact factor (IF) of Clinical Microbiology and Infection (CMI) has risen from 5.197 to 5.768. In journals on infectious diseases CMI is positioned behind The Lancet Infectious Diseases with an IF of 22.433, but not far behind Clinical Infectious Diseases (IF 8.886), Emerging Infectious Diseases (IF 6.751) and the Journal of Infectious Diseases (IF 5.997). This increase reflects the very hard work of the editorial board. From 2007 the impact factor has risen from 2.98 to 5.768. During this time, the volume of articles has almost doubled and the period for acceptance and rejection is among the best of the top 20 infectious diseases journals, with an average processing time of 35 days. The rejection rate is very high (82%), which may be frustrating in certain cases. CMI distinguishes itself through the themed sections, which offer original themes not tackled by other journals, and thus play an important role towards the opening of new fields of knowledge.

Gunnar Kahlmeter’s Garrod lecture on EUCAST published in JAC

Gunnar’s lecture on EUCAST and the future of breakpoints and susceptibility testing is published in the Journal of Antimicrobial Chemotherapy. He was asked to give the lecture when he was awarded the Garrod medal by the British Society for Antimicrobial Chemotherapy in 2014. The full citation is: The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement? Gunnar Kahlmeter, Journal of Antimicrobial Chemotherapy 2015; doi: 10.1093/jac/dkv145. 

Join the 9th European Congress on Tropical Medicine & International Health!

ECTMIH 2015 will take place from 6 – 10 September 2015 at the Congress Center Basel, Switzerland. It brings together some 2,000 of the most distinguished scientists and experts in the field of tropical medicine and international health. Throughout plenaries, seminars and various parallel scientific sessions, the conference will reflect on global health challenges, neglected diseases, the millennium development goals and what comes afterwards. The event will also offer a platform to reinforce and further promote public-private-partnerships and policy dialogue towards addressing global health challenges. Submit your late-breaking abstracts before 2 July 2015! 

 
 
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173 info@escmid.org
www.escmid.org
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.
 
You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.